Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy
Goon P, Sauzet O, Schuermann M, Oppel F, Shao SY, Scholtz L-U, Sudhoff H, Goerner M (2023)
npj Vaccines 8(1): 49.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Goon, PeterUniBi;
Sauzet, Odile;
Schuermann, Matthias;
Oppel, FelixUniBi;
Shao, SenYao;
Scholtz, Lars-UweUniBi;
Sudhoff, HolgerUniBi 
;
Goerner, Martin
;
Goerner, MartinAbstract / Bemerkung
**Abstract**
Recurrent Respiratory Papillomatosis(RRP) is a rare disease with severe morbidity. Treatment is surgical. Prevailing viewpoint is that prophylactic HPV vaccines do not have therapeutic benefit due to theirmodus operandi. Studies on HPV vaccination alongside surgery were meta-analysed to test effect on burden of disease. Databases were accessed Nov and Dec 2021 [PubMed, Cochrane, Embase and Web of Science]. Main outcome measured was: Mean paired differences in the number of surgeries or recurrences per month. Analyses was performed using: Random effect maximal likelihood estimation model using the Stata module Mataan(StataCorp. 2019.Stata Statistical Software: Release 16. College Station, TX:StataCorp LLC.) Our results foundn = 38 patients, suitable for syntheses with one previous meta-analyses (4 published, 2 unpublished studies)n = 63, total ofn = 101 patients. Analyses rendered an overall reduction of 0.123 recurrences or surgeries per month (95% confidence interval [0.064, 0.183]). Our meta-analyses concludes that HPV vaccine is a beneficial adjunct therapy alongside surgery
Recurrent Respiratory Papillomatosis(RRP) is a rare disease with severe morbidity. Treatment is surgical. Prevailing viewpoint is that prophylactic HPV vaccines do not have therapeutic benefit due to theirmodus operandi. Studies on HPV vaccination alongside surgery were meta-analysed to test effect on burden of disease. Databases were accessed Nov and Dec 2021 [PubMed, Cochrane, Embase and Web of Science]. Main outcome measured was: Mean paired differences in the number of surgeries or recurrences per month. Analyses was performed using: Random effect maximal likelihood estimation model using the Stata module Mataan(StataCorp. 2019.Stata Statistical Software: Release 16. College Station, TX:StataCorp LLC.) Our results foundn = 38 patients, suitable for syntheses with one previous meta-analyses (4 published, 2 unpublished studies)n = 63, total ofn = 101 patients. Analyses rendered an overall reduction of 0.123 recurrences or surgeries per month (95% confidence interval [0.064, 0.183]). Our meta-analyses concludes that HPV vaccine is a beneficial adjunct therapy alongside surgery
Erscheinungsjahr
2023
Zeitschriftentitel
npj Vaccines
Band
8
Ausgabe
1
Art.-Nr.
49
Urheberrecht / Lizenzen
eISSN
2059-0105
Page URI
https://pub.uni-bielefeld.de/record/2977978
Zitieren
Goon P, Sauzet O, Schuermann M, et al. Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines. 2023;8(1): 49.
Goon, P., Sauzet, O., Schuermann, M., Oppel, F., Shao, S. Y., Scholtz, L. - U., Sudhoff, H., et al. (2023). Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines, 8(1), 49. https://doi.org/10.1038/s41541-023-00644-8
Goon, Peter, Sauzet, Odile, Schuermann, Matthias, Oppel, Felix, Shao, SenYao, Scholtz, Lars-Uwe, Sudhoff, Holger, and Goerner, Martin. 2023. “Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy”. npj Vaccines 8 (1): 49.
Goon, P., Sauzet, O., Schuermann, M., Oppel, F., Shao, S. Y., Scholtz, L. - U., Sudhoff, H., and Goerner, M. (2023). Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines 8:49.
Goon, P., et al., 2023. Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines, 8(1): 49.
P. Goon, et al., “Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy”, npj Vaccines, vol. 8, 2023, : 49.
Goon, P., Sauzet, O., Schuermann, M., Oppel, F., Shao, S.Y., Scholtz, L.-U., Sudhoff, H., Goerner, M.: Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines. 8, : 49 (2023).
Goon, Peter, Sauzet, Odile, Schuermann, Matthias, Oppel, Felix, Shao, SenYao, Scholtz, Lars-Uwe, Sudhoff, Holger, and Goerner, Martin. “Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy”. npj Vaccines 8.1 (2023): 49.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 37005390
PubMed | Europe PMC
Suchen in
Google Scholar